Pharmacokinetics of linezolid in critically ill patients: impact of continuous venovenous haemofiltration.
暂无分享,去创建一个
M. Ranieri | V. Fanelli | F. D. De Rosa | G. di Perri | A. D’Avolio | R. Urbino | S. Corcione | S. Allegra
[1] E. Fiaccadori,et al. Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic review , 2016, Critical Care.
[2] C. Ronco,et al. Kinetics of Linezolid in Continuous Renal Replacement Therapy: An In Vitro Study , 2016, Therapeutic drug monitoring.
[3] V. Ranieri,et al. Pharmacokinetics of high dosage of linezolid in two morbidly obese patients. , 2015, The Journal of antimicrobial chemotherapy.
[4] V. Calvez,et al. Pharmacokinetics of high dosage of linezolid in two morbidly obese patients. , 2015, The Journal of antimicrobial chemotherapy.
[5] V. Ranieri,et al. Pharmacokinetics of linezolid during extracorporeal membrane oxygenation. , 2013, International journal of antimicrobial agents.
[6] A. R. Gascón,et al. Pharmacokinetic–pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries , 2012, European Journal of Clinical Microbiology & Infectious Diseases.